Trachyonychia - Nail and Distal Digit
Alerts and Notices
Important News & Links
Synopsis

Trachyonychia, or "20-nail dystrophy" (TND), refers to brittle, rough, and thin nails, often described as being sandpaper-like. Trachyonychia was first described by Alkiewicz in 1950 and later named TND by Hazelrigg in 1977. Trachyonychia may affect 1-20 nails, and severity may vary between different nails.
Clinically, trachyonychia is divided into 2 types: shiny and opaque. In the shiny type, there is ridging and pitting, but nails retain their natural luster. In the opaque type, which is generally more severe, nails are rough, brittle, and thin with ridging caused by superficial striations. In both types, there may be thickened cuticles, onychoschizia, and koilonychia.
Trachyonychia may affect all age groups. It most commonly affects children and is typically idiopathic. In children, it usually affects all 20 nails. Trachyonychia is reported in 4% of patients with alopecia areata. Other dermatologic disease associations are psoriasis, lichen planus, and, less commonly, atopic dermatitis, ichthyosis vulgaris, vitiligo, and pemphigus vulgaris. Systemic disease associations include amyloidosis, sarcoidosis, primary biliary cirrhosis, and hematologic disease. Drugs such as chemotherapeutic agents may cause trachyonychia.
Histopathology of trachyonychia typically shows spongiosis with inflammatory cell exocytosis into the nail epithelia. There may be findings of nail matrix lichen planus or psoriasis in some cases.
Clinically, trachyonychia is divided into 2 types: shiny and opaque. In the shiny type, there is ridging and pitting, but nails retain their natural luster. In the opaque type, which is generally more severe, nails are rough, brittle, and thin with ridging caused by superficial striations. In both types, there may be thickened cuticles, onychoschizia, and koilonychia.
Trachyonychia may affect all age groups. It most commonly affects children and is typically idiopathic. In children, it usually affects all 20 nails. Trachyonychia is reported in 4% of patients with alopecia areata. Other dermatologic disease associations are psoriasis, lichen planus, and, less commonly, atopic dermatitis, ichthyosis vulgaris, vitiligo, and pemphigus vulgaris. Systemic disease associations include amyloidosis, sarcoidosis, primary biliary cirrhosis, and hematologic disease. Drugs such as chemotherapeutic agents may cause trachyonychia.
Histopathology of trachyonychia typically shows spongiosis with inflammatory cell exocytosis into the nail epithelia. There may be findings of nail matrix lichen planus or psoriasis in some cases.
Codes
ICD10CM:
L60.3 – Nail dystrophy
SNOMEDCT:
238719003 – Twenty nail dystrophy
L60.3 – Nail dystrophy
SNOMEDCT:
238719003 – Twenty nail dystrophy
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
Best Tests
Subscription Required
Management Pearls
Subscription Required
Therapy
Subscription Required
Drug Reaction Data
Below is a list of drugs with literature evidence indicating an adverse association with this diagnosis. The list is continually updated through ongoing research and new medication approvals. Click on Citations to sort by number of citations or click on Medication to sort the medications alphabetically.
Subscription Required
References
Subscription Required
Last Reviewed:09/21/2017
Last Updated:06/24/2019
Last Updated:06/24/2019